Literature DB >> 18685488

Vascular and lymphatic properties of the superficial and deep lamina propria in Barrett esophagus.

Hejin P Hahn1, Aliakbar Shahsafaei, Robert D Odze.   

Abstract

A well-known type of mesenchymal/epithelial interaction occurs in Barrett esophagus (BE) characterized by the formation of a new, superficially located, muscularis mucosae (MM), which results in the division of the lamina propria (LP) into a superficial and deep compartment. The vascular and lymphatic properties of these 2 regions of LP are unknown. The risk of metastases of carcinomas that infiltrate these 2 anatomic areas also remains unclear. The aim of this study was to evaluate the density of blood vessels and lymphatic spaces within the superficial and deep LP and submucosa in patients with BE, and to compare the results to normal squamous-lined esophagus. Thirty esophago-gastrectomy specimens were stained immunohistochemically with CD31 (stains blood vessel and lymphatic endothelium) and D2-40 (stains lymphatic endothelium only). The density of CD31+ blood and lymphatic vessels (per 20 x field) in BE (superficial LP=37 and deep LP=38) was significantly lower compared with the LP of squamous-lined esophagus (68; P<0.001). However, the total number of blood and lymphatic vessels in the superficial and deep LP in BE was statistically similar to the LP of squamous-lined esophagus. The density of CD31+ blood and lymphatic vessels (per 20x field) in the submucosa of BE (21) was not significantly different from the submucosa of squamous-lined esophagus (23; P>0.05). We conclude that in BE, the "native" LP in squamous-lined esophagus is separated into 2 LP compartments (superficial and deep) by the formation of a new MM. These findings suggest that carcinomas that invade through the superficial MM into the deep LP should be considered "intramucosal" rather than "submucosal." Further outcome studies are needed to evaluate the risk of vascular/lymphatic metastasis in BE patients with different levels of LP invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685488     DOI: 10.1097/PAS.0b013e31817884fd

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

Review 1.  Barrett esophagus: histology and pathology for the clinician.

Authors:  Robert D Odze
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

2.  Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus.

Authors:  Yutaka Tomizawa; Tsung-Teh Wu; Kenneth K Wang
Journal:  Oncol Lett       Date:  2012-03-05       Impact factor: 2.967

3.  The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.

Authors:  Yichun Wang; Liyang Zhu; Wanli Xia; Liming Wu; Fan Wang
Journal:  World J Surg Oncol       Date:  2018-11-07       Impact factor: 2.754

4.  Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer.

Authors:  Tenglong Zhang; Jing Nie; Xiaojiang Liu; Zenglei Han; Ning Ding; Kai Gai; Yang Liu; Ling Chen; Chengye Guo
Journal:  Clin Transl Sci       Date:  2020-10-22       Impact factor: 4.689

Review 5.  Histopathology in barrett esophagus and barrett esophagus-related dysplasia.

Authors:  Andrea Grin; Catherine J Streutker
Journal:  Clin Endosc       Date:  2014-01-24

6.  Tumor location is a risk factor for lymph node metastasis in superficial Barrett's adenocarcinoma.

Authors:  Masayoshi Yamada; Ichiro Oda; Hirohito Tanaka; Seiichiro Abe; Satoru Nonaka; Haruhisa Suzuki; Shigetaka Yoshinaga; Aya Kuchiba; Kazuo Koyanagi; Hiroyasu Igaki; Hirokazu Taniguchi; Shigeki Sekine; Yutaka Saito; Yuji Tachimori
Journal:  Endosc Int Open       Date:  2017-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.